Synergy Between PCI With TAXUS and Cardiac Surgery: SYNTAX Extended Survival

Erasmus Medical Center2,636 enrolled

Overview

An investigator-driven, retrospective study to compare long-term survival-data (10-year follow-up) of patients with coronary artery disease (CAD), previously enrolled in the SYNTAX trial, who were randomized to percutaneous coronary intervention (PCI) using a paclitaxel (TAXUS) drug-eluting-stent (DES) or coronary artery bypass grafting (CABG).

Study Type

OBSERVATIONAL

Enrollment

2,636

Conditions

Coronary Artery Disease

Interventions

No intervention will take place for this retrospective and observational study.OTHER

No intervention will take place for this retrospective and observational study.

Eligibility

Sex: ALLMin age: 21 YearsMax age: 100 Years

Medical Language ↔ Plain English

Patients which have previously been enrolled in the SYNTAX trial (randomized and registry patients)

Outcomes

Primary Outcomes

Long-term survival status

All-cause death

Time frame: 10-year

Secondary Outcomes

Cause of death

Cause-specific death, separated in cardiovascular and non-cardiovascular death with specific causes for cardiovascular deaths.

Time frame: 10-year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.